MMP9 and autism: In this context, a recent study by Zhang et al. demonstrated that a 40 mg/kg dose of luteolin antagonized LRP1, reducing matrix metallopeptidase-9 (MMP9) expression and leading to significant improvements in autism-like behavior in rat models [224].